Angiotensin II promotes melanogenesis via angiotensin II type 1 receptors in human melanocytes

Liu,Li‑Hong; Fan,Xin; Li,Hai‑Tao; An,Xu‑Xi; Yang,Rong‑Ya

doi:10.3892/mmr.2015.3438

Angiotensin II promotes melanogenesis via angiotensin II type 1 receptors in human melanocytes

Authors:
- Li‑Hong Liu
- Xin Fan
- Hai‑Tao Li
- Xu‑Xi An
- Rong‑Ya Yang
View Affiliations

Affiliations: Graduate School, The Third Military Medical University, Chongqing 400038, P.R. China, Department of Dermatology, General Hospital of Beijing Military Region of PLA, Beijing 100700, P.R. China
Published online on: March 5, 2015 https://doi.org/10.3892/mmr.2015.3438
Pages: 651-656

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Angiotensin II (AngII) is a hormone with long‑established cardiovascular actions. Previous studies have revealed an additional role for AngII in the regulation of cutaneous wound healing. To evaluate the association between AngII and abnormal pigmentation of cutaneous wound healing, the present study used human melanocytes to investigate the effects of AngII on melanogenesis, and to elucidate the possible underlying mechanisms. Primary culture melanocytes were treated with AngII either alone or in combination with an AngII type 1 (AT1) receptor antagonist, losartan (LOS). The melanin content and tyrosinase activity were measured and reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) and western blotting were performed to assess the proteins involved in melanogenesis and the AT1 receptor. AngII regulated the mRNA expression of AT1 in the melanocytes. The melanin content and tyrosinase activity increased in response to treatment with AngII in a concentration‑dependent manner. RT‑qPCR and western blotting revealed that the AT1 receptor antagonist, LOS, eliminated this effect. These results provide a novel insight into the role of AngII and its associated signaling in melanogenesis.

View Figures

View References

1	Wisely JA, Hoyle E, Tarrier N and Edwards J: Where to start? Attempting to meet the psychological needs of burned patients. Burns. 33:736–746. 2007. View Article : Google Scholar : PubMed/NCBI
2	Zeitlin RE: Long-term psychosocial sequelae of paediatric burns. Burns. 23:467–472. 1997. View Article : Google Scholar
3	Singer AJ and Clark RA: Cutaneous wound healing. N Engl J Med. 341:738–746. 1999. View Article : Google Scholar : PubMed/NCBI
4	Rodgers K, Xiong S, Felix J, Roda N, Espinoza T, Maldonado S and Dizerega G: Development of angiotensin (1–7) as an agent to accelerate dermal repair. Wound Repair Regen. 9:238–247. 2001. View Article : Google Scholar : PubMed/NCBI
5	Kim JA, Berliner JA and Nadler JL: Angiotensin II increases monocyte binding to endothelial cells. Biochem Biophys Res Commun. 226:862–868. 1996. View Article : Google Scholar : PubMed/NCBI
6	Reddy HK, Sigusch H, Zhou G, Tyagi SC, Janicki JS and Weber KT: Coronary vascular hyperpermeability and angiotensin II. J Lab Clin Med. 126:307–315. 1995.PubMed/NCBI
7	Steckelings UM, Artuc M, Paul M, Stoll M and Henz BM: Angiotensin II stimulates proliferation of primary human keratinocytes via a non-AT1, non-AT2 angiotensin receptor. Biochem Biophys Res Commun. 229:329–333. 1996. View Article : Google Scholar : PubMed/NCBI
8	Takeda H, Katagata Y, Hozumi Y and Kondo S: Effects of angiotensin II receptor signaling during skin wound healing. Am J Pathol. 165:1653–1662. 2004. View Article : Google Scholar : PubMed/NCBI
9	Rodgers K, Abiko M, Girgis W, St Amand K, Campeau J and diZerega G: Acceleration of dermal tissue repair by angiotensin II. Wound Repair Regen. 5:175–183. 1997. View Article : Google Scholar : PubMed/NCBI
10	Steckelings UM, Wollschläger T, Peters J, Henz BM, Hermes B and Artuc M: Human skin: source of and target organ for angiotensin II. Exp Dermatol. 13:148–154. 2004. View Article : Google Scholar : PubMed/NCBI
11	Nozawa Y, Matsuura N, Miyake H, Yamada S and Kimura R: Effects of TH-142177 on angiotensin II-induced proliferation, migration and intracellular signaling in vascular smooth muscle cells and on neointimal thickening after balloon injury. Life Sci. 64:2061–2070. 1999. View Article : Google Scholar : PubMed/NCBI
12	Steckelings UM, Henz BM, Wiehstutz S, Unger T and Artuc M: Differential expression of angiotensin receptors in human cutaneous wound healing. Br J Dermatol. 153:887–893. 2005. View Article : Google Scholar : PubMed/NCBI
13	Otake AH, Mattar AL, Freitas HC, et al: Inhibition of angiotensin II receptor 1 limits tumor-associated angiogenesis and attenuates growth of murine melanoma. Cancer Chemother Pharmacol. 66:79–87. 2010. View Article : Google Scholar
14	Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:248–254. 1976. View Article : Google Scholar : PubMed/NCBI
15	Lei TC, Virador VM, Vieira WD and Hearing VJ: A melanocyte-keratinocyte coculture model to assess regulators of pigmentation in vitro. Anal Biochem. 305:260–268. 2002. View Article : Google Scholar : PubMed/NCBI
16	Virador VM, Kobayashi N, Matsunaga J and Hearing VJ: A standardized protocol for assessing regulators of pigmentation. Anal Biochem. 270:207–219. 1999. View Article : Google Scholar : PubMed/NCBI
17	Marin-Castaño ME, Elliot SJ, Potier M, et al: Regulation of estrogen receptors and MMP-2 expression by estrogens in human retinal pigment epithelium. Invest Ophthalmol Vis Sci. 44:50–59. 2003. View Article : Google Scholar
18	Peng Y, Kang Q, Cheng H, et al: Transcriptional characterization of bone morphogenetic proteins (BMPs)-mediated osteogenic signaling. J Cell Biochem. 90:1149–1165. 2003. View Article : Google Scholar : PubMed/NCBI
19	De Gasparo M, Catt KJ, Inagami T, Wright JW and Unger T: International union of pharmacology. XXIII The angiotensin II receptors. Pharmacol Rev. 52:415–472. 2000.PubMed/NCBI
20	Striker GE, Praddaude F, Alcazar O, Cousins SW and Marin-Castaño ME: Regulation of angiotensin II receptors and extracellular matrix turnover in human retinal pigment epithelium: roleof angiotensin II. Am J Physiol Cell Physiol. 295:C1633–C1646. 2008. View Article : Google Scholar : PubMed/NCBI
21	Olivares C and Solano F: New insights into the active site structure and catalytic mechanism of tyrosinase and its related proteins. Pigment Cell Melanoma Res. 22:750–760. 2009. View Article : Google Scholar : PubMed/NCBI
22	Yahata Y, Shirakata Y, Tokumaru S, et al: A novel function of angiotensin II in skin wound healing. Induction of fibroblast and keratinocyte migration by angiotensin II via heparin-binding epidermal growth factor (EGF)-like growth factor-mediated EGF receptor transactivation. J Biol Chem. 281:13209–13216. 2006. View Article : Google Scholar : PubMed/NCBI
23	Huang W, Yu LF, Zhong J, et al: Angiotensin II type 1 receptor expression in human gastric cancer and induces MMP2 and MMP9 expression in MKN-28 cells. Dig Dis Sci. 53:163–168. 2008. View Article : Google Scholar
24	Sarlos S, Rizkalla B, Moravski CJ, Cao Z, Cooper ME and Wilkinson-Berka JL: Retinal angiogenesis is mediated by an interaction between the angiotensin type 2 receptor, VEGF and angiopoietin. Am J Pathol. 163:879–887. 2003. View Article : Google Scholar : PubMed/NCBI
25	Wolf G: Angiotensin II and tubular development. Nephrol Dial Transplant. 17(Suppl 9): 48–51. 2002. View Article : Google Scholar : PubMed/NCBI
26	Kaschina E and Unger T: Angiotensin AT1/AT2 receptors: regulation, signalling and function. Blood Press. 12:70–88. 2003. View Article : Google Scholar : PubMed/NCBI
27	Iozumi K, Hoganson GE, Pennella R, Everett MA and Fuller BB: Role of tyrosinase as the determinant of pigmentation in cultured human melanocytes. J Invest Dermatol. 100:806–811. 1993. View Article : Google Scholar : PubMed/NCBI
28	Yamaguchi Y and Hearing VJ: Physiological factors that regulate skin pigmentation. Biofactors. 35:193–199. 2009. View Article : Google Scholar : PubMed/NCBI